BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15760918)

  • 1. Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas.
    Pedersen TX; Pennington CJ; Almholt K; Christensen IJ; Nielsen BS; Edwards DR; Rømer J; Danø K; Johnsen M
    Carcinogenesis; 2005 Jul; 26(7):1233-40. PubMed ID: 15760918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
    Szabova L; Chrysovergis K; Yamada SS; Holmbeck K
    Oncogene; 2008 May; 27(23):3274-81. PubMed ID: 18071307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
    Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
    Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
    Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
    Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
    Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A
    Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
    Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.
    Acuff HB; Sinnamon M; Fingleton B; Boone B; Levy SE; Chen X; Pozzi A; Carbone DP; Schwartz DR; Moin K; Sloane BF; Matrisian LM
    Cancer Res; 2006 Aug; 66(16):7968-75. PubMed ID: 16912171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.
    Juncker-Jensen A; Rømer J; Pennington CJ; Lund LR; Almholt K
    Mol Carcinog; 2009 Jul; 48(7):618-25. PubMed ID: 19058297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.
    Chekerov R; Klaman I; Zafrakas M; Könsgen D; Mustea A; Petschke B; Lichtenegger W; Sehouli J; Dahl E
    Neoplasia; 2006 Jan; 8(1):38-45. PubMed ID: 16533424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
    Haupt LM; Irving RE; Weinstein SR; Irving MG; Griffiths LR
    Mol Cell Probes; 2008 Apr; 22(2):83-9. PubMed ID: 17669621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
    Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
    Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
    J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.